Earningsreport

Q4/2018 12/31/2018 EPS -0.170 ZacksConsensus -0.170 ActVsEst 0.000 - In-Line

TherapeuticsMD, Inc.  (TXMD) 
NASDAQ:AMEX Investor Relations: ir.therapeuticsmd.com